American Hospital Association October 6, 2023

The Drug Enforcement Administration and Substance Abuse and Mental Health Services Administration Oct. 6 released a temporary rule extending telehealth prescribing flexibilities for buprenorphine and other controlled substances for new practitioner-patient relationships through Dec. 31, 2024. The agencies previously extended the flexibilities through Nov. 11, 2024, while they consider changes to proposed rules released in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Govt Agencies, HHS, Patient / Consumer, Provider, Technology, Telehealth
Related Articles:
Teladoc expands virtual sitter capabilities
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?
Hospital recovery at risk if Congress doesn’t extend telehealth, Fitch Ratings says
End of home health, telehealth coverage threatens hospitals' recovery: Fitch

Share This Article